Close
Help




JOURNAL

Cancer Growth and Metastasis

Serum YKL-40 Levels in Patients with Esophageal Squamous Cell Carcinoma

Submit a Paper


Cancer Growth and Metastasis 2011:4 1-5

Original Research

Published on 04 Apr 2011

DOI: 10.4137/CGM.S7046


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Cancer Growth and Metastasis

Abstract

Aims and background: YKL-40 is a glycoprotein secreted by macrophages, neutrophils and malignant tumor cells. YKL-40 is expressed and secreted by several types of tumors. The aim of this study examined the clinical usefulness of YKL-40 for detection in esophageal squamous cell carcinoma (ESCC).

Methods: Using ELISA kits, we measured the concentration of YKL-40 in serum from 100 patients with ESCC and compared this concentration with healthy population.

Results: We found significantly higher serum levels of YKL-40 in patients with ESCC compared to the healthy population

(P < 0.0001).

Conclusions: These results suggested that regarding serum YKL-40 as a tumor marker could be benefical in the early clinical diagnosis.



Downloads

PDF  (599.20 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)


Sharing


What Your Colleagues Say About Cancer Growth and Metastasis
My experience with the review stages and manuscript processing in Cancer Growth and Metastasis has been of excellence. The fine balance of times utilized for proper scientific assessment of the material and quality control is greatly commended.
Dr Carlos Telleria (Sanford School of Medicine of The University of South Dakota, Vermillion, SD, USA)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube